Navigation Links
Medicine quality in Philippines and region strengthened with Philippine FDA's accreditation
Date:7/12/2010

Rockville, Md., July 12, 2010 In an effort that will contribute to raising the quality of medicines in the Philippines and surrounding regions, the Laboratory Services Division (LSD) of the Philippine Food and Drug Administration (FDA) has attained the internationally recognized accreditation for testing and calibration laboratories, International Organization for Standardization/ International Electrotechnical Commission (ISO/IEC) 17025:2005. The FDA celebrates this achievement with its partners who assisted the laboratory in earning accreditation, including the U.S. Agency for International Development (USAID) and the Promoting the Quality of Medicines (PQM) Program, implemented by the U.S. Pharmacopeial Convention (USP).

"This is a milestone not only for the FDA, but for the people of the Philippines and the surrounding region," said Ms. Maria Lourdes C. Santiago, M.Sc. M.M., chief, LSD. We are demonstrating our commitment to public health by adherence to international standards for laboratory quality management. We greatly appreciate the timely support from USAID and PQM, which allowed us to anticipate and address issues prior to the formal accreditation process."

Added Ms. Nancy Tacandong, director, FDA, "I am thankful that USAID and PQM came at an opportune time and helped FDA in gaining accreditation. Filipino consumers and export industries stand to benefit from this achievement of the FDA."

PQM staff conducted training at the Philippines FDA on Good Laboratory Practices (GLP), Dissolution testing, and High Performance Liquid Chromatography (HPLC) analysis focused on the fixed-dose combination anti-tuberculosis (TB) medicine containing pyrazinamide, rifampicin, isoniazid and ethambutol. One of the main goals of this training was to equip analysts at both the main FDA site and the satellite laboratories in Cebu and Davao with the necessary analytical skills to determine the quality of anti-TB medicines in the Philippines. '/>"/>

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Is Frequency the Future of Medicine or an Ancient Mystery Revealed?
2. Impact of Azmacort Withdrawal Brought to Light in Medicine Community
3. Atlanta School of Sleep Medicine Offers Physician Board Review Course in October 2010
4. Breast milk transmits drugs and medicines to the baby
5. SEK100 million ($12.83 million) for Karolinska Institutets research into regenerative medicine
6. SNMs 2010 Annual Meeting reveals latest developments in molecular imaging and nuclear medicine
7. Sung-Cheng (Henry) Huang receives 2010 Benedict Cassen Prize for Research in Nuclear Medicine
8. Applied nuclear physics for biomedicine, nuclear security and basic science
9. US, Ukraine agree to share standards for quality of medicines
10. LocumTenens.com Announces Expansion into Emergency Medicine Staffing Physician Recruiting Firm Adds New Specialty to Its Service Lines
11. UIC to host Institute of Medicine Meeting on diabetes and obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... The American Society of ... engaged in the field of organ transplantation, today ... Immunology Research Network (TIRN), a professional network ... modern organ transplantation continues to diversify, AST determined ... more opportunities for physicians, scientists and researchers to ...
(Date:7/28/2014)... one of the UK,s most common respiratory diseases has ... disease (COPD) is the name for a collection of ... to the lungs. Often linked to smoking, it ... admissions in the UK, with a high proportion of ... , A team of researchers, led by ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 With California ... it is welcome news that a fire blanket ... current protection is under development by SunSeeker Enterprises, Inc. ... to protect spacecraft from the extreme heat of re-entry ... both firefighters and homes. , “Our firefighters routinely lay ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Drorit Silverman, ... unveiled new plans to raise investment capital through her ... fitness concept in the United States. , According to ... of 24/7 fitness centers provide a great window of ... rapidly expanding space. In addition to this, Silverman looks ...
(Date:7/28/2014)... Medicine (BUSM) report variants in a new gene, PLXNA4, ... (AD). The discovery of this novel genetic association may ... specifically. These findings appear in the Annals of ... dementia affecting 5.4 million Americans including 13 percent of ... percent of people age 85 and older. Genetic factors ...
Breaking Medicine News(10 mins):Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 2Health News:American Society of Transplantation (AST) Launches Transplantation and Immunology Research Network (TIRN); Aims to Expand Research Collaboration & Funding 3Health News:New research to tackle treatment for lung disease 2Health News:New research to tackle treatment for lung disease 3Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Researchers identify potential biomarker for AD 2
... Community,in partnership with the Forum, Unveil Disease "Hot Spots" ... (KCP) - an alliance of patient advocates, ... improve quality of care for individuals with kidney disease ... regarding the racial disparity among those suffering from Chronic ...
... Sysmex America, Inc., a leading medical diagnostic instrument ... availability of the Sysmex WAM eLearning program to ... across the U.S. Sysmex WAM eLearning gives customers ... Sysmex WAM users and as a tool to ...
... entitled Motorcycle Cancer? is sending a ... seat extremely low frequency electromagnetic field (ELF EMF) ... Randall Dale Chipkar. "Science proves electromagnetic danger and ... read up to 500 milliGauss of ELF EMF ...
... PLC Systems Inc. (OTC Bulletin Board: PLCSF) announced today ... financial results for the fourth quarter and year ended December ... 2009. The company plans to host a conference call to ... day. The call may be joined via telephone by dialing ...
... Highland Good Steward Management ("HGSM") today announced it ... investment adviser, as a sub adviser to Highland ... HGSM focuses on incorporating environmental, social ... William "Doug" Douglass III, co-founder of K2, said, ...
... Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce ... Administration (FDA) Level II Baseline Inspection and received a ... standard for the FDA to periodically perform unannounced inspections ... the FDA validates the Company,s quality system and its ...
Cached Medicine News:Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 2Health News:Kidney Care Partners Raises Alarm on Racial Disparities in Kidney Disease; Joins With National Minority Quality Forum to Educate Public, Congress During National Kidney Month 3Health News:Sysmex America Introduces On Demand Middleware Training Tool 2Health News:Motorcycle Cancer Risk: Motorcycle Cop Cancer Concern from ELF EMFs Penetrating Motorcycle Seats 2Health News:K2 Advisors Named Investment Advisor by Highland Good Steward Management 2Health News:Solos Endoscopy, Inc. Successfully Completes FDA Inspection 2
(Date:7/28/2014)... , 28 luglio 2014 ResMed (NYSE: ... di prodotti per la cura dei disturbi respiratori del ... ha avuto un,ingiunzione permanente in Germania contro il produttore ... proibisce la vendita di apparecchiature da indossare in testa, ... e le maschere 220. La sentenza della Corte Regionale ...
(Date:7/28/2014)... 2014   Cardioxyl Pharmaceuticals, Inc. announced today ... CXL-1427, a novel potential treatment for acute decompensated heart ... company has now initiated dosing of hospitalized patients with ... designed to further evaluate the drug,s safety and tolerability ... Phase I clinical trial evaluated the safety and tolerability ...
(Date:7/28/2014)... CLARA, Calif. , July 28, 2014  ProteinSimple ... assay for the Simple Western. This new assay allows users ... For the first time, Simple Western users can analyze ... The Simple Western has changed protein analysis as ... hassles of Western blot protocols - no messy gels, ...
Breaking Medicine Technology:ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2ProteinSimple Says "Never Run a Gel Again!" 2
... California Cryobank (CCB), the nation,s leading ... branch in Indianapolis, IN.  In conjunction with General ... York, Cambridge, and Palo Alto as California Cryobank,s sixth ... HCLD(ABB), and John Critser, PhD., General BioTech is a ...
... with active moderate to severe rheumatoid arthritis (RA) inadequately ... (Humira ® ) and who were actively switched to ... at week 10, and sustained response through week 26 ... from the RESTART study were presented for the first ...
Cached Medicine Technology:Nation's Leading Sperm Bank Opens Branch in Indianapolis, IN 2New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 2New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 3New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 4New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 5New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 6New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement 7
... is for arthroscopic and open soft tissue repair ... procedural steps. It may be used with ... in conjunction with,anchors or screws (including suture pre-assembled ... tip permits the placement of a variety of ...
Knot pusher/suture retriever...
... The RC Retractor comes ... allow for superficial or deep ... Retractor permits retraction in three ... inferior. The fiber optic ...
Shoulder rasp...
Medicine Products: